Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Friedman

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Movement Disorders Clinical Practice|September 13, 2021
Commentary: Galactosemia Diagnosis by Whole Exome Sequencing Later in LifeJennifer Friedman, Sara Lucas-Del-Pozo, David Moreno-Martinez, et al.
The American Journal of Pathology|October 5, 2010
Sera from preeclampsia patients elicit symptoms of human disease in mice and provide a basis for an in vitro predictive assaySatyan Kalkunte, Roland Boij, Wendy Norris, et al.
Clinical Genetics|October 5, 2024
Consolidating the Role of Mutated ATP2B2 in Neurodevelopmental and Cerebellar PathologiesAntonia M Stehr, Jerica Lenberg, Jennifer Friedman, et al.
Culture, Health & Sexuality|April 26, 2019
Experiences with abortion counselling in Mexico City and Colombia: addressing women's fears and concernsBrianna Keefe-Oates, Shelly Makleff, Eleuthera Sa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 27, 2014
Assessment of safety in newborns of mothers participating in clinical trials of vaccines administered during pregnancyFlor M Munoz, Leonard E Weisman, Jennifer S Read, et al.
HGG Advances|October 27, 2025
Splicing and frameshift variants in QSER1 may be involved in developmental phenotypesMegan C Fischer, Linda M Reis, Jerica Lenberg, et al.
Nature Chemical Biology|December 21, 2021
Characterization of a patient-derived variant of GPX4 for precision therapyHengrui Liu, Farhad Forouhar, Tobias Seibt, et al.
Human Molecular Genetics|October 8, 2021
Caenorhabditis elegans provides an efficient drug screening platform for GNAO1-related disorders and highlights the potential role of caffeine in controlling dyskinesiaMartina Di Rocco, Serena Galosi, Enrico Lanza, et al.
Pediatric Neurology|October 18, 2024
The Face and Features of RNU4-2: A New, Common, Recognizable, Yet Hidden Neurodevelopmental DisorderKristen Barbour, Matthew N Bainbridge, Kristen Wigby, et al.
Molecular Genetics & Genomic Medicine|June 2, 2021
Ending a diagnostic odyssey: Moving from exome to genome to identify cockayne syndromeJennifer Friedman, Lynne M Bird, Richard Haas, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Movement Disorders Clinical Practice|September 13, 2021
Commentary: Galactosemia Diagnosis by Whole Exome Sequencing Later in LifeJennifer Friedman, Sara Lucas-Del-Pozo, David Moreno-Martinez, et al.
The American Journal of Pathology|October 5, 2010
Sera from preeclampsia patients elicit symptoms of human disease in mice and provide a basis for an in vitro predictive assaySatyan Kalkunte, Roland Boij, Wendy Norris, et al.
Clinical Genetics|October 5, 2024
Consolidating the Role of Mutated ATP2B2 in Neurodevelopmental and Cerebellar PathologiesAntonia M Stehr, Jerica Lenberg, Jennifer Friedman, et al.
Culture, Health & Sexuality|April 26, 2019
Experiences with abortion counselling in Mexico City and Colombia: addressing women's fears and concernsBrianna Keefe-Oates, Shelly Makleff, Eleuthera Sa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 27, 2014
Assessment of safety in newborns of mothers participating in clinical trials of vaccines administered during pregnancyFlor M Munoz, Leonard E Weisman, Jennifer S Read, et al.
HGG Advances|October 27, 2025
Splicing and frameshift variants in QSER1 may be involved in developmental phenotypesMegan C Fischer, Linda M Reis, Jerica Lenberg, et al.
Nature Chemical Biology|December 21, 2021
Characterization of a patient-derived variant of GPX4 for precision therapyHengrui Liu, Farhad Forouhar, Tobias Seibt, et al.
Human Molecular Genetics|October 8, 2021
Caenorhabditis elegans provides an efficient drug screening platform for GNAO1-related disorders and highlights the potential role of caffeine in controlling dyskinesiaMartina Di Rocco, Serena Galosi, Enrico Lanza, et al.
Pediatric Neurology|October 18, 2024
The Face and Features of RNU4-2: A New, Common, Recognizable, Yet Hidden Neurodevelopmental DisorderKristen Barbour, Matthew N Bainbridge, Kristen Wigby, et al.
Molecular Genetics & Genomic Medicine|June 2, 2021
Ending a diagnostic odyssey: Moving from exome to genome to identify cockayne syndromeJennifer Friedman, Lynne M Bird, Richard Haas, et al.
Pageof 9